<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02756000</url>
  </required_header>
  <id_info>
    <org_study_id>ZEM-CARD-003</org_study_id>
    <nct_id>NCT02756000</nct_id>
  </id_info>
  <brief_title>Timing of Complete Revascularization for Multivessel Coronary Artery Disease in STEMI</brief_title>
  <acronym>MVD</acronym>
  <official_title>Appropriate Timing of Complete Revascularization for Multivessel Coronary Artery Disease After Culprit Only Primary Percutaneous Coronary Intervention (PCI) for ST Elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Hospital Center Zemun</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute for cardiovascular diseases Vojvodina, Novi Sad, Serbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Military Medical Academy, Belgrade, Serbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinical Center Kragujevac, Kragujevac, Serbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinical Hospital Center Zemun</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will compare clinical outcomes between complete revascularization during
      hospitalization for ST elevation myocardial infarction (STEMI) and intervention after 30 days
      and intervention based on outpatient non-invasive ischemia testing in patients with
      multivessel coronary artery disease (MVD) presenting with first ever ST elevation myocardial
      infarction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is prospective, randomized, multicentre, open label study in patients with ST
      elevation myocardial infarction (STEMI) with multivessel coronary artery disease (MVD)
      defined as &gt;70% stenosis in a non-culprit vessel, initially treated with culprit only primary
      PCI. The patients will be enrolled in four high volume PCI centers after successful culprit
      only primary PCI and then randomly assigned to one of three treatment arms:1. complete
      revascularization of all non-culprit significant lesions in a single session during initial
      hospitalization; 2. same revascularization in a single session after 30 days;
      3.revascularization or it's deferral based on ischemia testing using Dobutamin stress
      echocardiography. The study will explore differences in occurrence of major adverse
      cardio-cerebral events (cardiac death, repeated myocardial infarction, cerebrovascular
      accident and repeated revascularization) and complications of interventions during 12 months
      follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>major adverse cardio-cerebral events</measure>
    <time_frame>one year</time_frame>
    <description>cardiac death, repeated myocardial infarction, cerebrovascular accident and repeated revascularization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cardiac death</measure>
    <time_frame>one year</time_frame>
    <description>Occurence of death caused by cardiac condition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>repeated myocardial infarction</measure>
    <time_frame>one year</time_frame>
    <description>Occurrence of repeated myocardial infarction in the study groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications of percutaneous coronary intervention</measure>
    <time_frame>one year</time_frame>
    <description>Occurrence of vascular complications of PCI, contrast induced nephropathy (CIN) and bleeding events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stent thrombosis</measure>
    <time_frame>two years</time_frame>
    <description>Occurrence of stent thrombosis based on Associated Research Consortium (ARC) criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospitalization for heart failure</measure>
    <time_frame>one year</time_frame>
    <description>Occurrence of hospitalization for heart failure in the study groups</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">616</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>complete PCI at initial hospitalization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Staged, complete revascularization of all non-culprit significant lesions in a single PCI session during initial hospitalization for ST elevation myocardial infarction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>complete PCI after 30 days</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Staged, complete revascularization of all non-culprit significant lesions in a single PCI session after 30 days from initial hospitalization for ST elevation myocardial infarction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dobutamine stress testing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Revascularization by PCI or deferral of revascularization of non-culprit coronary artery lesions based on ischemia testing using Dobutamin stress echocardiography</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCI</intervention_name>
    <description>percutaneous angioplasty and stent implantation in coronary artery with significant atherosclerosis and stenosis</description>
    <arm_group_label>complete PCI at initial hospitalization</arm_group_label>
    <arm_group_label>complete PCI after 30 days</arm_group_label>
    <arm_group_label>Dobutamine stress testing</arm_group_label>
    <other_name>percutaneous coronary intervention</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>dobutamine stress echocardiography</intervention_name>
    <description>Echocardiographic stress test of provoked myocardial ischemia using dobutamine</description>
    <arm_group_label>Dobutamine stress testing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical and electrocardiographic signs of first ever ST elevation myocardial
             infarction (chest pain lasting less than 12 hours with persistent ST elevation of â‰¥
             1mm in two contiguous leads on ECG recording)

          -  Multivessel coronary artery disease (MVD) on initial coronary angiogram, defined as
             visually assessed stenosis of more than 70% of any of the non-culprit vessels

          -  Treated with primary PCI of infarct related artery (IRA) only.

        Exclusion Criteria:

          -  Hemodynamically unstable patients defined as presence of cardiogenic shock,
             intraaortic balloon pump (IABP) implantation and mechanical ventilation prior, during
             and after primary PCI;

          -  Presence of significant valvular disease;

          -  Decision that patient needs to be treated with coronary artery bypass graft (CABG)
             and/or valvular replacement or reconstruction surgery after initial culprit only PCI;

          -  Myocardial infarction is caused by stent thrombosis:

          -  Chronic total occlusion of any of the coronary arteries on initial angiogram;

          -  Previously treated by CABG surgery;

          -  Estimated life expectancy less than one year.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aleksandar N Neskovic, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Clinical Hospital Center Zemun</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ivan S Ilic, MD</last_name>
    <phone>+381641374455</phone>
    <email>ivan1ilic@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aleksandra Janicijevic, MD</last_name>
    <phone>+38162511410</phone>
    <email>aleksandra.janicijevic@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Military Medical Academy</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nemanja Djenic, MD</last_name>
      <phone>+38163277383</phone>
      <email>drnemanjadjenic@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Slobodan Obradovic, MD, PhD</last_name>
      <email>sloba.d.obradovic@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital Center Zemun</name>
      <address>
        <city>Belgrade</city>
        <zip>11080</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivan Ilic, MD</last_name>
      <phone>+381641374455</phone>
      <email>ivan1ilic@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Gojko Obradovic, MD</last_name>
      <phone>+381641391139</phone>
      <email>drgojko@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Miliovoje Cerovic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aleksandar N Neskovic, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Srdjan Kafedzic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Center Kragujevac</name>
      <address>
        <city>Kragujevac</city>
        <zip>34000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nikola Jagic, MD, PhD</last_name>
      <phone>+381600321542</phone>
      <email>njagic@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute for cardiovascular diseases Vojvodine</name>
      <address>
        <city>Novi Sad</city>
        <zip>21000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilija Srdanovic, MD, PhD</last_name>
      <phone>+38163575821</phone>
      <email>ilijasrd@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Miroslav Bikicki, MD, PhD</last_name>
      <phone>+38163590015</phone>
      <email>tadon@sbb.com</email>
    </contact_backup>
    <investigator>
      <last_name>Mila Kovacevic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Serbia</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2016</study_first_submitted>
  <study_first_submitted_qc>April 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2016</study_first_posted>
  <last_update_submitted>April 28, 2016</last_update_submitted>
  <last_update_submitted_qc>April 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Hospital Center Zemun</investigator_affiliation>
    <investigator_full_name>Ivan Ilic</investigator_full_name>
    <investigator_title>Head of interventional cardiology diagnostics</investigator_title>
  </responsible_party>
  <keyword>myocardial infarction</keyword>
  <keyword>percutaneous coronary intervention</keyword>
  <keyword>multivessel coronary artery disease</keyword>
  <keyword>dobutamine stress echocardiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dobutamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

